Ticker

Analyst Price Targets — FREQ

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
December 8, 2022 9:24 amChardan Capital$1.40$0.41Benzinga Chardan Capital Initiates Coverage On Frequency Therapeutics with Buy Rating, Announces Price Target of $7

No recent news available for FREQ.

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for FREQ.

No House trades found for FREQ.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top